One of the most immediate ways we’ll experience the benefits of rescheduling cannabis is on medical and scientific research. Keeping cannabis in the Schedule I category imposed massive regulatory barriers that made it difficult to study the plant, even for renowned and established clinical or scientific researchers. Strict DEA requirements and severely limited supply of cannabis that could be studied, were all major hurdles for researchers.
The rise of the pot parent makes sense. Today's parents grew up skeptical of drug-war…
The data shows that approximately 4.4% of 8 million urine-based drug tests in the workplace…
Except the science keeps saying it isn't simple at all. The THC percentage is a…
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…